sui: A Comparative Study Minisling Versus Transobturator (TOT)Sling

Sponsor
Federal University of São Paulo (Other)
Overall Status
Completed
CT.gov ID
NCT01094353
Collaborator
(none)
145
1
2
85
1.7

Study Details

Study Description

Brief Summary

A study to compare efficacy in surgical treatment for SUI (Stress Urinary Incontinence), tot with minisling.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Mini-sling
  • Procedure: Transobturator
Phase 4

Detailed Description

eligibility criteria was : female stress urinary incontinence

Study Design

Study Type:
Interventional
Actual Enrollment :
145 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Clinical, prospective, single-center, randomized controlled trial comparing the efficacy and safety of a single-incision mini-sling and a transobturator midurethral sling for female stress urinary incontinence (SUI) treatment.Clinical, prospective, single-center, randomized controlled trial comparing the efficacy and safety of a single-incision mini-sling and a transobturator midurethral sling for female stress urinary incontinence (SUI) treatment.
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
The participants were randomly allocated to a single-incision mini-sling or a transobturator midurethral tape by a simple randomization procedure using a random number generator computer program. Randomization was performed at the moment of inclusion by a nurse blinded to women's histories. Group assign- ment was concealed in consecutively numbered, sealed, opaque envelopes that were opened in the operating room just before the procedure.
Primary Purpose:
Treatment
Official Title:
Randomised Trial of Ophira™ Minisling System and Unitape™ for the Treatment of Stress Urinary Incontinence in Women
Actual Study Start Date :
Jun 1, 2008
Actual Primary Completion Date :
Dec 1, 2011
Actual Study Completion Date :
Jul 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Mini-sling

The minisling Ophira™ is a new intervention therapeutic option for surgical treatment in women with stress urinary incontinence. It is made of polypropylene monofilament mesh, held between two self-anchoring polypropylene columns in a fishbone design connected to two delivering needles.

Procedure: Mini-sling
The minisling is a new intervention therapeutic option for surgical treatment in women with stress urinary incontinence. It is made of polypropylene monofilament mesh, held between two self-anchoring polypropylene columns in a fishbone design connected to two delivering needles.
Other Names:
  • Mini-sling Ophira™
  • Active Comparator: Transobturator

    Transobturator sling Unitape™ is an outside-in approach therapeutic option for surgical treatment in women with stress urinary incontinence

    Procedure: Transobturator
    Transobturator sling Unitape™ is an outside-in approach therapeutic option for surgical treatment in women with stress urinary incontinence
    Other Names:
  • Transobturator Sling Unitape™
  • Outcome Measures

    Primary Outcome Measures

    1. to assess efficacy between tot with minisling in cure in women with stress urinary incontinence [one year]

      to assess efficacy and safety of minisling and transobturator sling in treatment of female stress urinary incontinence

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 90 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • clinical and urodynamic diagnosis of SUI in patients between 18 and 90 years
    Exclusion Criteria:
    • postvoid residual urine volume more than 100 ml, coagulation disorders, current urinary tract infection, sequelae of previous radiation therapy of the pelvis, anticoagulant therapy, vulvovaginitis, and anesthesia contraindication

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Federal University of São Paulo São Paulo Brazil

    Sponsors and Collaborators

    • Federal University of São Paulo

    Investigators

    • Principal Investigator: Ana LG Pascom, Pg, Federal University of São Paulo

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ana Livia Garcia Pascom, M.D., Federal University of São Paulo
    ClinicalTrials.gov Identifier:
    NCT01094353
    Other Study ID Numbers:
    • ophira
    First Posted:
    Mar 26, 2010
    Last Update Posted:
    Jun 21, 2017
    Last Verified:
    Jun 1, 2017
    Keywords provided by Ana Livia Garcia Pascom, M.D., Federal University of São Paulo
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 21, 2017